Shilpa Medicare Limited — Important, 20-12-2024: General Updates

Shilpa Medicare Limited has successfully obtained the Good Manufacturing Practice (GMP) Certification for its Unit VII located in Nacharam, Hyderabad, following an inspection by EMA Europe. This inspection took place from September 24 to 26, 2024, marking a significant achievement as it was the first GMP inspection for the Quality Control laboratory at this unit, which is involved in testing drug substances, raw materials, and finished products.

The laboratory, which is also approved by the USFDA, plays a vital role in ensuring the quality and compliance of products destined for markets in the US, EU, and beyond. This certification enhances Shilpa's credibility in the international market and supports its strategic objective of strengthening its pharmaceutical capabilities in niche segments such as Oncology. Positive outlook as this milestone can potentially expand market opportunities and improve Shilpa's competitive positioning in the industry.